Luciferase-IN-1

CAS No. 10205-56-8

Luciferase-IN-1( —— )

Catalog No. M35026 CAS No. 10205-56-8

Luciferase-IN-1, a luciferase inhibitor, is utilized in the study of bacterial and fungal infections.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 52 In Stock
10MG 85 In Stock
25MG 146 In Stock
50MG 242 In Stock
100MG 370 In Stock
500MG 849 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Luciferase-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Luciferase-IN-1, a luciferase inhibitor, is utilized in the study of bacterial and fungal infections.
  • Description
    Luciferase-IN-1 is a luciferase inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Reactive Oxygen Species | Antibacterial | Antifungal
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    10205-56-8
  • Formula Weight
    254.35
  • Molecular Formula
    C15H14N2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 10 mg/mL (39.32 mM; Ultrasonic (<60°C); )
  • SMILES
    N(C)(C)C1=CC=C(C2=NC=3C(S2)=CC=CC3)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Auld DS, et al. A basis for reduced chemical library inhibition of firefly luciferase obtained from directed evolution. J Med Chem. 2009;52(5):1450-1458.?
molnova catalog
related products
  • Oxazolone

    Oxazolone has been used as a haptenizing agent which can induce an inflammatory reaction in adult zebrafish intestinal tissues and this can be used as a model for gene expression studies of the two forms of inflammatory bowel disease like Crohn’s disease and ulcerative colitis.

  • Isoxaflutole

    Isoxaflutole is a low toxic herbicide and has been marketed as a substitute for atrazine.

  • Minzasolmin

    Minzasolmin(DLX-313) is an alpha-synuclein misfolding inhibitor for the study of Parkinson's disease.